Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

The role of miR-155 in cigarette smoke-induced pulmonary inflammation and COPD.

De Smet EG, Van Eeckhoutte HP, Avila Cobos F, Blomme E, Verhamme FM, Provoost S, Verleden SE, Venken K, Maes T, Joos GF, Mestdagh P, Brusselle GG, Bracke KR.

Mucosal Immunol. 2019 Dec 9. doi: 10.1038/s41385-019-0241-6. [Epub ahead of print]

PMID:
31819170
2.

Influence of azithromycin and allograft rejection on the post-lung transplant microbiota.

Spence CD, Vanaudenaerde B, Einarsson GG, Mcdonough J, Lee AJ, Johnston E, Verleden GM, Elborn JS, Dupont LJ, Van Herck A, Gilpin DF, Vos R, Tunney MM, Verleden SE.

J Heart Lung Transplant. 2019 Nov 21. pii: S1053-2498(19)31759-0. doi: 10.1016/j.healun.2019.11.007. [Epub ahead of print]

PMID:
31812487
3.

Computed Tomography Total Airway Count is Associated with Number of Micro-CT Terminal Bronchioles.

Kirby M, Tanabe N, Vasilescu DM, Cooper JD, McDonough JE, Verleden SE, Vanaudenaerde BM, Sin DD, Tan WC, Coxson HO, Hogg JC.

Am J Respir Crit Care Med. 2019 Nov 7. doi: 10.1164/rccm.201910-1948LE. [Epub ahead of print] No abstract available.

PMID:
31697561
4.

Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation: a single-center experience and review of literature.

Lebeer M, Kaes J, Lambrech M, Vanstapel A, Beeckmans H, Ambrocio GPL, Vanaudenaerde BM, Verleden SE, Verbeken EK, Neyrinck AP, Ceulemans LJ, Van Raemdonck DE, Verleden GM, Vos R; Leuven Lung Transplant Group.

Transpl Int. 2019 Oct 23. doi: 10.1111/tri.13544. [Epub ahead of print]

PMID:
31643104
5.

Mortality after lung transplantation: a single-centre cohort analysis.

Raskin J, Vanstapel A, Verbeken EK, Beeckmans H, Vanaudenaerde BM, Verleden SE, Neyrinck AP, Ceulemans LJ, Van Raemdonck DE, Verleden GM, Vos R; Leuven Lung Transplant Group.

Transpl Int. 2019 Oct 15. doi: 10.1111/tri.13540. [Epub ahead of print]

PMID:
31612514
6.

Transcriptional regulatory model of fibrosis progression in the human lung.

McDonough JE, Ahangari F, Li Q, Jain S, Verleden SE, Herazo-Maya J, Vukmirovic M, DeIuliis G, Tzouvelekis A, Tanabe N, Chu F, Yan X, Verschakelen J, Homer RJ, Manatakis DV, Zhang J, Ding J, Maes K, De Sadeleer L, Vos R, Neyrinck A, Benos PV, Bar-Joseph Z, Tantin D, Hogg JC, Vanaudenaerde BM, Wuyts WA, Kaminski N.

JCI Insight. 2019 Nov 14;4(22). pii: 131597. doi: 10.1172/jci.insight.131597.

7.

Re-visiting the HLA dogma.

Roux A, Verleden SE.

Eur Respir J. 2019 Aug 29;54(2). pii: 1901440. doi: 10.1183/13993003.01440-2019. Print 2019 Aug. No abstract available.

PMID:
31467186
8.

Airway morphometry in COPD with bronchiectasis: a view on all airway generations.

Everaerts S, McDonough JE, Verleden SE, Josipovic I, Boone M, Dubbeldam A, Mathyssen C, Serré J, Dupont LJ, Gayan-Ramirez G, Verschakelen J, Hogg JC, Verleden GM, Vanaudenaerde BM, Janssens W.

Eur Respir J. 2019 Nov 7;54(5). pii: 1802166. doi: 10.1183/13993003.02166-2018. Print 2019 Nov.

PMID:
31467117
9.

CARM1 regulates senescence during airway epithelial cell injury in COPD pathogenesis.

Sarker RSJ, Conlon TM, Morrone C, Srivastava B, Konyalilar N, Verleden SE, Bayram H, Fehrenbach H, Yildirim AÖ.

Am J Physiol Lung Cell Mol Physiol. 2019 Nov 1;317(5):L602-L614. doi: 10.1152/ajplung.00441.2018. Epub 2019 Aug 28.

PMID:
31461302
10.

Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction.

Sacreas A, Taupin JL, Emonds MP, Daniëls L, Van Raemdonck DE, Vos R, Verleden GM, Vanaudenaerde BM, Roux A, Verleden SE; and the Leuven Lung Transplant Group.

Eur Respir J. 2019 Nov 7;54(5). pii: 1900847. doi: 10.1183/13993003.00847-2019. Print 2019 Nov.

PMID:
31439680
11.

Outcome of lung transplantation in non-idiopathic pulmonary fibrosis interstitial lung disease.

Bode H, Verleden SE, Wuyts WA, Yserbyt J, Verleden GM, Vos R.

Clin Transplant. 2019 Oct;33(10):e13661. doi: 10.1111/ctr.13661. Epub 2019 Aug 6.

PMID:
31286560
12.

Chronic lung allograft dysfunction: light at the end of the tunnel?

Verleden SE, Vos R, Verleden GM.

Curr Opin Organ Transplant. 2019 Jun;24(3):318-323. doi: 10.1097/MOT.0000000000000632.

PMID:
31090642
13.

Myeloid-Derived Suppressor Cells in Lung Transplantation.

Heigl T, Singh A, Saez-Gimenez B, Kaes J, Van Herck A, Sacreas A, Beeckmans H, Vanstapel A, Verleden SE, Van Raemdonck DE, Verleden G, Vanaudenaerde BM, Hartl D, Vos R.

Front Immunol. 2019 Apr 26;10:900. doi: 10.3389/fimmu.2019.00900. eCollection 2019.

14.

The Notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary disease.

Ballester-López C, Conlon TM, Ertüz Z, Greiffo FR, Irmler M, Verleden SE, Beckers J, Fernandez IE, Eickelberg O, Yildirim AÖ.

EBioMedicine. 2019 May;43:562-575. doi: 10.1016/j.ebiom.2019.03.054. Epub 2019 May 4.

15.

Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT.

Glanville AR, Verleden GM, Todd JL, Benden C, Calabrese F, Gottlieb J, Hachem RR, Levine D, Meloni F, Palmer SM, Roman A, Sato M, Singer LG, Tokman S, Verleden SE, von der Thüsen J, Vos R, Snell G.

J Heart Lung Transplant. 2019 May;38(5):483-492. doi: 10.1016/j.healun.2019.03.008. Epub 2019 Apr 3. No abstract available.

PMID:
31027539
16.

Chronic lung allograft dysfunction: light at the end of the tunnel?

Verleden SE, Vos R, Verleden GM.

Curr Opin Organ Transplant. 2019 Apr 1. doi: 10.1097/MOT.0000000000000632. [Epub ahead of print]

PMID:
30939492
17.

Prone Positioning During Ex Vivo Lung Perfusion Influences Regional Edema Accumulation.

Ordies S, Frick AE, Claes S, Schols D, Verleden SE, Van Raemdonck DE, Neyrinck AP; Leuven Lung Transplant Group.

J Surg Res. 2019 Jul;239:300-308. doi: 10.1016/j.jss.2019.02.003. Epub 2019 Mar 19.

PMID:
30901722
18.

The pleural mesothelium and transforming growth factor-β1 pathways in restrictive allograft syndrome: A pre-clinical investigation.

Sacreas A, von der Thüsen JH, van den Bosch TPP, Weynand B, Verbeken EK, Debbaut C, Van Raemdonck DE, Vos R, Verleden SE.

J Heart Lung Transplant. 2019 May;38(5):570-579. doi: 10.1016/j.healun.2019.02.001. Epub 2019 Feb 6.

PMID:
30819647
19.

Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.

Yang JYC, Verleden SE, Zarinsefat A, Vanaudenaerde BM, Vos R, Verleden GM, Sarwal RD, Sigdel TK, Liberto JM, Damm I, Watson D, Sarwal MM.

J Clin Med. 2019 Feb 13;8(2). pii: E241. doi: 10.3390/jcm8020241.

20.

Double-lung versus heart-lung transplantation for precapillary pulmonary arterial hypertension: a 24-year single-center retrospective study.

Brouckaert J, Verleden SE, Verbelen T, Coosemans W, Decaluwé H, De Leyn P, Depypere L, Nafteux P, Van Veer H, Meyns B, Rega F, Van De Velde M, Poortmans G, Rex S, Neyrinck A, Van den Berghe G, Vlasselaers D, Van Cleemput J, Budts W, Vos R, Quarck R, Belge C, Delcroix M, Verleden GM, Van Raemdonck D.

Transpl Int. 2019 Jul;32(7):717-729. doi: 10.1111/tri.13409. Epub 2019 Mar 5.

PMID:
30735591
21.

Phenotypical diversity of airway morphology in chronic lung graft vs. host disease after stem cell transplantation.

Verleden SE, McDonough JE, Schoemans H, Knoop C, Verschakelen J, Dubbeldam A, Boone MN, Van Hoorebeke L, Verbeken E, Weynand B, Van Raemdonck D, Verleden GM, Vos R, Vanaudenaerde BM.

Mod Pathol. 2019 Jun;32(6):817-829. doi: 10.1038/s41379-019-0203-2. Epub 2019 Feb 5.

PMID:
30723292
22.

Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.

Van Herck A, Frick AE, Schaevers V, Vranckx A, Verbeken EK, Vanaudenaerde BM, Sacreas A, Heigl T, Neyrinck AP, Van Raemdonck D, Dupont LJ, Yserbyt J, Verleden SE, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Mar;38(3):252-259. doi: 10.1016/j.healun.2018.12.006. Epub 2018 Dec 14.

PMID:
30686699
23.

Montelukast in chronic lung allograft dysfunction after lung transplantation.

Vos R, Eynde RV, Ruttens D, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck DE, Verleden GM; Leuven Lung Transplant Group.

J Heart Lung Transplant. 2019 May;38(5):516-527. doi: 10.1016/j.healun.2018.11.014. Epub 2018 Dec 6.

PMID:
30638839
24.

Bone morphogenetic protein 6 (BMP-6) modulates lung function, pulmonary iron levels and cigarette smoke-induced inflammation.

Verhamme FM, De Smet EG, Van Hooste W, Delanghe J, Verleden SE, Joos GF, Brusselle GG, Bracke KR.

Mucosal Immunol. 2019 Mar;12(2):340-351. doi: 10.1038/s41385-018-0116-2. Epub 2018 Dec 12.

PMID:
30542109
25.

Freedom from chronic lung allograft dysfunction (CLAD) or CLAD-free survival: What's in a name?

Verleden GM, Verleden SE, Vos R.

J Heart Lung Transplant. 2019 Jan;38(1):1-2. doi: 10.1016/j.healun.2018.11.005. Epub 2018 Nov 15. No abstract available.

PMID:
30497817
26.

Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study.

Tuyls S, Verleden SE, Wuyts WA, Yserbyt J, Vos R, Verleden GM.

Transpl Int. 2019 Apr;32(4):399-409. doi: 10.1111/tri.13382. Epub 2018 Dec 21.

PMID:
30488486
27.

Validation of a post-transplant chronic lung allograft dysfunction classification system.

Van Herck A, Verleden SE, Sacreas A, Heigl T, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck D, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Feb;38(2):166-173. doi: 10.1016/j.healun.2018.09.020. Epub 2018 Oct 4.

PMID:
30391199
28.

The common rejection module in chronic rejection post lung transplantation.

Sacreas A, Yang JYC, Vanaudenaerde BM, Sigdel TK, Liberto JM, Damm I, Verleden GM, Vos R, Verleden SE, Sarwal MM.

PLoS One. 2018 Oct 5;13(10):e0205107. doi: 10.1371/journal.pone.0205107. eCollection 2018.

29.

Role of 18F-FDG PET/CT in Restrictive Allograft Syndrome After Lung Transplantation.

Verleden SE, Gheysens O, Goffin KE, Vanaudenaerde BM, Verbeken EK, Weynand B, Van Raemdonck DE, Verleden GM, Vos R.

Transplantation. 2019 Apr;103(4):823-831. doi: 10.1097/TP.0000000000002393.

PMID:
30086092
30.

Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI.

Sun N, Fernandez IE, Wei M, Witting M, Aichler M, Feuchtinger A, Burgstaller G, Verleden SE, Schmitt-Kopplin P, Eickelberg O, Walch A.

Eur Respir J. 2018 Sep 15;52(3). pii: 1702314. doi: 10.1183/13993003.02314-2017. Print 2018 Sep.

PMID:
30072508
31.

Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.

Vos R, Wuyts WA, Gheysens O, Goffin KE, Schaevers V, Verleden SE, Van Herck A, Sacreas A, Heigl T, McDonough JE, Yserbyt J, Godinas L, Dupont LJ, Neyrinck AP, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Verleden GM.

Am J Transplant. 2018 Dec;18(12):3045-3059. doi: 10.1111/ajt.15019. Epub 2018 Aug 17.

32.

A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis.

McDonough JE, Martens DS, Tanabe N, Ahangari F, Verleden SE, Maes K, Verleden GM, Kaminski N, Hogg JC, Nawrot TS, Wuyts WA, Vanaudenaerde BM.

Respir Res. 2018 Jul 9;19(1):132. doi: 10.1186/s12931-018-0838-4.

33.

Clinical behaviour of patients exposed to organic dust and diagnosed with idiopathic pulmonary fibrosis.

De Sadeleer LJ, Verleden SE, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, Nemery B, Verleden GM, Hermans F, Vanaudenaerde BM, Wuyts WA.

Respirology. 2018 Dec;23(12):1160-1165. doi: 10.1111/resp.13342. Epub 2018 Jun 13.

PMID:
29897160
34.

The aging lung: tissue telomere shortening in health and disease.

Everaerts S, Lammertyn EJ, Martens DS, De Sadeleer LJ, Maes K, van Batenburg AA, Goldschmeding R, van Moorsel CHM, Dupont LJ, Wuyts WA, Vos R, Gayan-Ramirez G, Kaminski N, Hogg JC, Janssens W, Verleden GM, Nawrot TS, Verleden SE, McDonough JE, Vanaudenaerde BM.

Respir Res. 2018 May 11;19(1):95. doi: 10.1186/s12931-018-0794-z.

35.

Cholesterol metabolism promotes B-cell positioning during immune pathogenesis of chronic obstructive pulmonary disease.

Jia J, Conlon TM, Sarker RS, Taşdemir D, Smirnova NF, Srivastava B, Verleden SE, Güneş G, Wu X, Prehn C, Gao J, Heinzelmann K, Lintelmann J, Irmler M, Pfeiffer S, Schloter M, Zimmermann R, Hrabé de Angelis M, Beckers J, Adamski J, Bayram H, Eickelberg O, Yildirim AÖ.

EMBO Mol Med. 2018 May;10(5). pii: e8349. doi: 10.15252/emmm.201708349.

36.

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.

Ruttens D, Verleden SE, Demeyer H, Van Raemdonck DE, Yserbyt J, Dupont LJ, Vanaudenaerde BM, Vos R, Verleden GM.

PLoS One. 2018 Apr 6;13(4):e0193564. doi: 10.1371/journal.pone.0193564. eCollection 2018.

37.

Analysis of airway pathology in COPD using a combination of computed tomography, micro-computed tomography and histology.

Tanabe N, Vasilescu DM, Kirby M, Coxson HO, Verleden SE, Vanaudenaerde BM, Kinose D, Nakano Y, Paré PD, Hogg JC.

Eur Respir J. 2018 Feb 14;51(2). pii: 1701245. doi: 10.1183/13993003.01245-2017. Print 2018 Feb.

38.

Immediate post-operative broncho-alveolar lavage IL-6 and IL-8 are associated with early outcomes after lung transplantation.

Verleden SE, Martens A, Ordies S, Neyrinck AP, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.

Clin Transplant. 2018 Apr;32(4):e13219. doi: 10.1111/ctr.13219. Epub 2018 Feb 23.

PMID:
29405435
39.

The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis.

von der Thüsen JH, Vandermeulen E, Vos R, Weynand B, Verbeken EK, Verleden SE.

Mod Pathol. 2018 May;31(5):780-790. doi: 10.1038/modpathol.2017.180. Epub 2018 Jan 12.

40.

Prevention of chronic rejection after lung transplantation.

Van Herck A, Verleden SE, Vanaudenaerde BM, Verleden GM, Vos R.

J Thorac Dis. 2017 Dec;9(12):5472-5488. doi: 10.21037/jtd.2017.11.85. Review.

41.

Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.

Verleden SE, Vanaudenaerde BM, Emonds MP, Van Raemdonck DE, Neyrinck AP, Verleden GM, Vos R.

Eur Respir J. 2017 Nov 16;50(5). pii: 1701248. doi: 10.1183/13993003.01248-2017. Print 2017 Nov.

42.

Chronic lung allograft dysfunction phenotypes and treatment.

Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM.

J Thorac Dis. 2017 Aug;9(8):2650-2659. doi: 10.21037/jtd.2017.07.81. Review.

43.

Solid Organ Transplantation in Sarcoidosis.

Yserbyt J, Wuyts WA, Verleden SE, Verleden GM, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Vos R.

Semin Respir Crit Care Med. 2017 Aug;38(4):538-545. doi: 10.1055/s-0037-1602383. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750467
44.

An optimized non-destructive protocol for testing mechanical properties in decellularized rabbit trachea.

Den Hondt M, Vanaudenaerde BM, Maughan EF, Butler CR, Crowley C, Verbeken EK, Verleden SE, Vranckx JJ.

Acta Biomater. 2017 Sep 15;60:291-301. doi: 10.1016/j.actbio.2017.07.035. Epub 2017 Jul 21.

PMID:
28739545
45.

Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Van Raemdonck DE, Verleden GM, Roobrouck VD, Claes S, Schols D, Verbeken E, Verfaillie CM, Neyrinck AP.

Stem Cell Res Ther. 2017 Jul 5;8(1):159. doi: 10.1186/s13287-017-0603-5.

46.

CT-Based Local Distribution Metric Improves Characterization of COPD.

Hoff BA, Pompe E, Galbán S, Postma DS, Lammers JJ, Ten Hacken NHT, Koenderman L, Johnson TD, Verleden SE, de Jong PA, Mohamed Hoesein FAA, van den Berge M, Ross BD, Galbán CJ.

Sci Rep. 2017 Jun 7;7(1):2999. doi: 10.1038/s41598-017-02871-1.

47.

A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors.

Martens A, Van Raemdonck DE, Smits J, Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM, Degezelle K, Desschans B, Neyrinck AP.

Transpl Int. 2017 Oct;30(10):1002-1010. doi: 10.1111/tri.12990. Epub 2017 Jul 13.

48.

A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Verleden GM, Verbeken EK, Van Raemdonck DE, Claes S, Schols D, Chalopin M, Katz I, Farjot G, Neyrinck AP.

Med Gas Res. 2017 Mar 30;7(1):28-36. doi: 10.4103/2045-9912.202907. eCollection 2017 Jan-Mar.

49.

The Effect of Immunosuppression on Airway Integrity.

Bellon H, Vandermeulen E, Verleden SE, Heigl T, Vriens H, Lammertyn E, Verlinden L, Vanhove T, Verstuyf M, Hoet P, Vos R, Verleden GM, Vanaudenaerde BM.

Transplantation. 2017 Dec;101(12):2855-2861. doi: 10.1097/TP.0000000000001809.

PMID:
28471870
50.

Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.

Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12983. Epub 2017 May 8.

PMID:
28383790

Supplemental Content

Loading ...
Support Center